Neurological Disorders

An Introduction to Neurological Disorders

The immune and nervous systems have numerous interactions that impact on health and disease. The most well-known autoimmune neurological disorder is multiple sclerosis (MS), which is characterized by an inflammatory autoimmune attack on the myelin sheath and subsequent neurodegeneration. The immune system is also activated in other neurological disorders, including Alzheimer’s and Parkinson’s diseases, amyotrophic lateral sclerosis (ALS), Huntington’s disease, chronic depression and schizophrenia. Treatments for MS include immunosuppression; immunomodulation ; leukocyte trafficking interference; and immune cell depletion. Further understanding of the balance between beneficial and pathological effects of the immune system on neuronal development will facilitate the development of novel therapies.

Browse video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and peer-reviewed articles from the journal portfolio. This is complemented by a range of educational activities from our expert faculty, with patient outcomes at the forefront.

Neurological Disorders Content

David Leppert, MSVirtual2020 – Potential of Neutrophil Granulocyte Markers in CSF to Differentiate NMOSD and MOGAD from MS

It was a pleasure to hear from David Leppert (University Hospital Basel and University of Basel, Basel, Switzerland) on his late-breaking presentation about the exciting potential of neutrophil granulocyte markers in the cerebrospinal fluid to differentiate neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD) from multiple sclerosis (MS) in the acute disease phase. […]

Neurological Disorders

Mya C Schiess, MDS 2020 – Stem Cell Therapy for Parkinson’s Disease (Part 1)

Mya C Schiess (McGovern Medical School at UTHealth, Houston, TX, USA) discusses promising findings from a phase I study (ClinicalTrials.gov identifier: NCT02611167), which was the focus of her presentation entitled: Allogeneic bone marrow-derived mesenchymal stem cells safety and tolerability in idiopathic Parkinson’s disease. Questions 1. What is known about the role of inflammation in the […]

Neurological Disorders

Mya C Schiess, MDS 2020 – Stem Cell Therapy for Parkinson’s Disease (Part 2)

Mya C Schiess (McGovern Medical School at UTHealth, Houston, TX, USA) discusses promising findings from a phase I study (ClinicalTrials.gov identifier: NCT02611167), which was the focus of her presentation entitled: Allogeneic bone marrow-derived mesenchymal stem cells safety and tolerability in idiopathic Parkinson’s disease. Questions 1. Could you tell us about the design of your phase […]

Feedback

Feedback

FILTER YOUR SEARCH

Content Type:

Speciality:

Conference:

Neurological Disorders

An Introduction to Neurological Disorders